not marketed by stockhouse
we really didn't get much press from stockhouse. certainly not as much as organigram got. seems that bedrocan prefers to tweet on twitter which I personally find to be kind of useless as an information site. they also seem to have leaned towards tmx which also missed the boat imho. bedrocan has got to be more timely with their information for investors. I know they have restraints in regards to advertising medical marijuana but I can't imagine that they can't inform potential investors. other drug manufacturers can advertise their product. this needs to be rectified by policy makers. bedrocan did e-mail me some updates but still haven't answered some of my questions directed to them. a little promotion wouldn't hurt the stock price. I am an investor now!